2024-01-17 00:38:48
Hsinchu, Oct. 13, 2021 /PRNewswire/ — Brain Navi announced the completion of the 100th case using its neurosurgical navigation robot NaoTrac. The 100th case was reported by Dr. Hao-Yu Chuang, head of the neurosurgery department at Annan Hospital in Tainan, Taiwan.
“It is my pleasure to witness this important milestone demonstrating the continued clinical acceptance of the NaoTrac surgical navigation robot. “I am pleased to continue to offer this state-of-the-art surgical technology to my patients,” said Dr. Hao-Yu Chuang. “One of the main advantages compared to other systems is that we can view the cranial anatomy in any patient position, including side and prone , can capture accurately.”
The system has already been installed in several hospitals across Taiwan. The director of the neurosurgical department of China Medical University Hospital, Chun-Chung Chen, said: “In the past, we might only treat ICH blood clot blindly, now we can plan the route, check in real time, and perform the procedure perfectly.” A additional director, Dr. Jeng-Hung Guo, said: “The rapid registration of NaoTrac results in shorter operation time and faster recovery of patients. The NaoTrac has performed very well in intracerebral hemorrhage, especially in hematomas with a volume of less than 30 ml, but with severe symptoms, and offers these patients an alternative solution instead of waiting for self-absorption.”
The very first user of the NaoTrac surgical robot is Hualien Tzu Chi Medical Center, which has been using the system for brain surgeries since the very first clinical case on November 7, 2018. Superintendent Dr. Shinn-Zong Lin said: “NaoTrac is exactly what all neurosurgeons want. It can make every doctor’s dream come true and enable patients with disabilities to return to life.” Professor Tsung-Lang Chiu published the first article regarding NaoTrac in a medical journal, demonstrating its effectiveness and economic benefits: “The NaoTrac “The robotic system can be easily integrated into our practice and our workflows and brings efficiency advantages to our neurosurgeons and hospitals.”
To eliminate lengthy and frustrating registration processes, NaoTrac leverages computer vision technology and completes patient and instrument registration within 30 seconds to 3 minutes. The NaoTrac system received CE Mark in April 2021 and Taiwan FDA approval in July 2022. During initial launch and international meetings, Brain Navi was able to gather valuable feedback from numerous neurosurgeons and integrate these ideas into the NaoTrac platform to meet market needs.
Dr. Jerry Chen, CEO of Brain Navi, said: “We are very pleased with the fact that all of these 100 procedures were completed without any complications. 2024 will be the year that marks the beginning of our international expansion as, in addition to Taiwan, we will also work with partners in the USA, Europe, Japan, the Middle East, Latin America and Malaysia. This will allow us to introduce this technology to more hospitals to streamline OR workflows, ultimately benefiting more patients.”
Information regarding Brain Navi:
Brain Navi Biotechnology, a leading Taiwanese surgical robotics company, specializes in the design and development of innovative navigation and robotic surgery technologies. The company’s proprietary Surface Mapping Auto-Registration Technology (SMART) represents a significant surgical breakthrough by integrating machine vision, robotics and artificial recognition for streamlined surgical procedures and real-time imaging, ensuring minimally invasive results. NaoTrac’s rapid patient registration and automatic surgical instrument registration allow the surgeon to effortlessly plan trajectory, and the robot ensures precise autonomous navigation to the desired target.
Questions & Contact:
Gokhan Zorlubas,
business development manager,
[email protected]; Zoe Lee,
Assistant Marketing Manager,
[email protected]; LinkedIn:
1705453307
#Brain #Navi #reports #100th #surgical #procedure #performed #NaoTrac